ELLEN SUGAREK: Open Payments
NPI 1831372259 · BRYAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$860 in 64 payments from 15 companies in 2025. Trend: 2023 $1,003 · 2024 $1,366 · 2025 $860
Food & beverage: $860
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $290 |
| Amgen Inc. | 28 | $175 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $65 |
| Merck Sharp & Dohme LLC | 3 | $51 |
| Baxter Healthcare | 2 | $43 |
| Novo Nordisk Inc | 2 | $40 |
| ABIOMED | 1 | $32 |
| Kestra Medical Technology Services, Inc. | 1 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $28 |
| Abbott Laboratories | 1 | $23 |
Products named: LEQVIO, REPATHA, LifeVest, VERQUVO, Hillrom - Carnation Ambulatory Monitor, Ozempic, Assure WCD, Kerendia.
Industry payments across TX — which companies pay providers there.
